外科學科

Medicine & Life Sciences

1. Angiotensin II 16%
2. Apoptosis 51%
3. Appendectomy 14%
4. Appendicitis 13%
5. Autophagy 21%
6. Bariatric Surgery 16%
7. Biomarkers 12%
8. Brain 16%
9. Breast 16%
10. Breast Neoplasms 59%
11. Carcinogenesis 16%
12. Cardiac Myocytes 20%
13. Cardiomegaly 20%
14. Catenins 25%
15. Cell Death 11%
16. Cell Line 14%
17. Cell Movement 24%
18. Cell Proliferation 14%
19. Cohort Studies 24%
20. Colonic Neoplasms 31%
21. Colorectal Neoplasms 45%
22. Compression Fractures 12%
23. Confidence Intervals 36%
24. Curcumin 13%
25. Databases 19%
26. Down-Regulation 26%
27. Drug Therapy 17%
28. Epithelial-Mesenchymal Transition 16%
29. ErbB Receptors 14%
30. garcinol 11%
31. Gastrectomy 14%
32. Gastric Bypass 14%
33. Genes 19%
34. Glioblastoma 27%
35. Glioma 23%
36. Glucose 11%
37. glucose-regulated proteins 26%
38. Growth 18%
39. Heart 12%
40. Hepatocellular Carcinoma 38%
41. Heterografts 11%
42. Hypertension 11%
43. In Vitro Techniques 21%
44. Incidence 19%
45. Inflammation 16%
46. Laparoscopy 21%
47. Learning Curve 13%
48. Length of Stay 15%
49. Liver 18%
50. Lung 12%
51. Lung Neoplasms 20%
52. Mesenchymal Stem Cells 17%
53. Meta-Analysis 100%
54. MicroRNAs 22%
55. Mortality 20%
56. Neoplasm Metastasis 39%
57. Neoplasms 65%
58. Neoplastic Stem Cells 27%
59. Nicotine 21%
60. Nicotinic Receptors 22%
61. Non-Small Cell Lung Carcinoma 12%
62. Odds Ratio 20%
63. ovatodiolide 15%
64. Oxidative Stress 16%
65. Oxygen 11%
66. p38 Mitogen-Activated Protein Kinases 12%
67. Pain 18%
68. Parkinson Disease 11%
69. Pharmaceutical Preparations 12%
70. Phosphatidylinositol 3-Kinases 14%
71. Platelet-Rich Plasma 11%
72. Population 26%
73. Proteins 22%
74. pterostilbene 16%
75. PubMed 14%
76. Quality of Life 12%
77. Radiosurgery 15%
78. Randomized Controlled Trials 68%
79. Reactive Oxygen Species 15%
80. Rectal Neoplasms 32%
81. Recurrence 18%
82. Resveratrol 12%
83. Robotics 27%
84. Safety 13%
85. Sleep 13%
86. Stem Cells 19%
87. Stroke 12%
88. Surgeons 13%
89. Survival 22%
90. Systematic Reviews 57%
91. Taiwan 68%
92. Temozolomide 13%
93. Therapeutics 48%
94. Transplants 11%
95. Traumatic Brain Injury 47%
96. Triple Negative Breast Neoplasms 14%
97. Up-Regulation 19%
98. Vertebroplasty 12%
99. Wounds and Injuries 37%